Monday 18 September 2017

Global Obstetrics and Gynecology Scissors Market Professional Survey Report by Radiant Insights

Obstetrics and gynecology scissors are used in various surgical procedures for quick incision. Scissors such as umbilical cord cutting, bandage, stitch, dissecting, episiotomy, and other such are used in gynecology and obstetrics. These scissors are generally made using rigid stainless steel that offers them with toughness. Ob-GYN scissors are available in various configurations such as:Obstetrics and gynecology scissors are used in various surgical procedures for quick incision. Scissors such as umbilical cord cutting, bandage, stitch, dissecting, episiotomy, and other such are used in gynecology and obstetrics. These scissors are generally made using rigid stainless steel that offers them with toughness. Ob-GYN scissors are available in various configurations such as:

• Blunt/sharp blades
• Blunt/blunt blades
• Sharp/sharp blades

Episiotomy Braun-Sadler Scissors:

These scissors are used during episiotomy. It is a surgical incision of the perineum performed during childbirth. Braun Sadler scissors make it possible for the gynecologist to control the angle and depths of incision. They further allow easy repair of the tissues.

The report “Global Obstetrics and Gynecology Scissors Market Professional Survey Report 2017” is available now at https://www.radiantinsights.com/research/global-obstetrics-and-gynecology-scissors-market-professional-survey-report-2017

Stitch Scissors:

Primary usage of the stitch scissors is for the removal or application of sutures. These scissors are also used as one of the important gynecological instruments. In obstetrics and gynecology, they are used after the delivery. These scissors are made using stainless steel as it is a strong and long lasting material.

Umbilical Cord Cutting Scissors:

The umbilical cord cutting scissors, one of the vital gynecological instruments, are used to cut the umbilical cord that is attached to the placenta.

Market Overview:

According to a new report made available by Radiant Insights, Inc.; the obstetrics and gynecology scissors market in United States is expected to grow rapidly over the forecast period. Prevalence of complications during childbirth can impel this growth. Unhealthy eating habits, high prevalence of various health issues, such as obesity and high cholesterol can lead to complicated childbirth. Such health issues in women may need complex surgeries during childbirth. All these factors can impel demand over the forecast period (2012 to 2022).

Read more related reports by Radiant Insights: https://www.radiantinsights.com/research/global-obstetrics-and-gynecology-scissors-market-professional-survey-report-2017/request-sample

Market Competitors

Few of the prominent participants operating in the ob-gyn scissors market in United States are ASANUS Medizintechnik GmbH; Olympus Medical Systems Corp.; Surtex Instruments Ltd.; Sontec Instruments, Inc.; and Scanlon International, Inc.Most market players undertake some essential business strategies to maintain their market positions. Some of these strategies include extensive investments and efforts toward R&D, development of novel technologies product launches, mergers & acquisitions, and regional expansions.

Tuesday 12 September 2017

Graft vs Host Disease (GVHD) Treatment Market will grow at a CAGR of 7.15% during 2017-2021: Radiant Insights

Graft-versus-host disease (GVHD) is an immune-mediated disease, which results from a multifaceted interaction amongst donor and recipient's adaptive immunity. GVHD is an induced indication and emerges post organ or tissue transplant. The probability of developing GVHD is higher in allogeneic transplant, a transplant where donor's organ/cell are used for transplantation compared with autologous transplant, a transplant where individual's cells have been used for transplant.

Covered in this report

The report covers the present scenario and the growth prospects of the global graft vs host disease (GVHD) treatment market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
To access full, click here: https://www.radiantinsights.com/research/global-graft-vs-host-disease-gvhd-treatment-market-2017-2021

Global Graft vs Host Disease (GVHD) Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bristol-Myers Squibb
  • Novartis
  • Pfizer
  • F. Hoffmann-La Roche
Other prominent vendors
  • Abbott
  • AbbVie
  • Allergan
  • Anterogen
  • Astellas Pharma
  • Athersys
  • Baxter
  • Caladrius
  • Cellular Biomedicine Group
  • Cipla
  • Eisai
  • Eli Lilly
  • GlaxoSmithKline
  • Glenmark
  • Helsinn Healthcare
  • Heron Therapeutics
  • Incyte Corporation
  • IPCA Laboratories
  • Kadmon Holdings
  • Lupin
  • Osiris Therapeutics
  • RedHill
  • Sanofi
  • Shire
  • Sun Pharmaceutical Industries
  • Takeda Pharmaceutical
  • ViaCyte             
Request free sample copy of this report @ https://www.radiantinsights.com/research/global-graft-vs-host-disease-gvhd-treatment-market-2017-2021/request-sample

Market driver
  • Increased prevalence of cancer
  • For a full, detailed list, view our report
Market challenge
  • Off-label use of drugs
  • For a full, detailed list, view our report
Market trend
  • Inorganic growth strategies
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Global Wearable Medical Devices Market will grow at a CAGR of 9.46% during the period 2017-2021: Radiant Insights

Wearable medical devices are autonomous, non-invasive (NI) devices with sensors, which are worn by people. They detect and monitor changes in the body signatures of various areas and organs. Wearable medical devices include diagnostic wearable medical devices and therapeutic wearable medical devices. Diagnostic wearable devices include pulse oximeters, glucose monitoring devices, blood pressure (BP) monitors, wearable patches, and activity trackers.

To access full Wearable Medical Devices Market Research Report, click here: https://www.radiantinsights.com/research/global-wearable-medical-devices-market-2017-2021

The report covers the present scenario and the growth prospects of the global wearable medical devices market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Global Wearable Medical Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Fitbit
• Garmin
• OMRON
• Philips Healthcare
• Sonova

Request free sample copy of this report @ https://www.radiantinsights.com/research/global-wearable-medical-devices-market-2017-2021/request-sample

Other prominent vendors
• GN Store Nord
• Jawbone
• LifeWatch
• Nokia
• Polar Electro
• Starkey Hearing Technologies
• Tandem Diabetes Care
Market driver
• Increasing prevalence of chronic diseases
• For a full, detailed list, view our report
Market challenge
• High cost of devices
• For a full, detailed list, view our report
Market trend
• Emergence of innovative wearable medical devices
• For a full, detailed list, view our report